The Full Wiki

More info on Alemtuzumab

Alemtuzumab: Quiz


Question 1: A significant complication of therapy with alemtuzumab is that it significantly increases the risk for opportunistic infections, in particular, reactivation of ________.
Hepatitis BAIDSCytomegalovirusErythema infectiosum

Question 2: It is also used under ________ protocols for treatment of some autoimmune diseases, such as multiple sclerosis, in which it shows promise.
Medical researchClinical trialClinical trial protocolPlacebo-controlled study

Question 3: bcr-abl (Dasatinib, ________, Nilotinib)

Question 4: Alemtuzumab targets CD52, a protein present on the surface of mature ________, but not on the stem cells from which these lymphocytes are derived.
LymphocyteAdaptive immune systemThymocyteImmune system

Question 5: lymphoid: ________ (Ibritumomab, Ofatumumab, Rituximab, Tositumomab)

Question 6: Alemtuzumab (marketed as Campath, MabCampath or Campath-1H) is a monoclonal antibody used in the treatment of ________ (CLL), cutaneous T-cell lymphoma (CTCL) and T-cell lymphoma.
B-cell chronic lymphocytic leukemiaHairy cell leukemiaHodgkin's lymphomaAcute lymphoblastic leukemia

Question 7: Alemtuzumab is also used in some conditioning regimens for ________ and kidney transplantation.
Hematopoietic stem cell transplantationGraft-versus-host diseaseImmunosuppressive drugOrgan transplant

Question 8: It is also possible that perturbation of suppressor T cell populations by Campath-1H may precipitate ________.
AutoimmunityImmune disorderHypersensitivityAutoimmune disease

Question 9: Early tests at ________ suggest that alemtuzumab might be useful in treating and even reversing the effects of multiple sclerosis.
University of OxfordUniversity of EdinburghUniversity of CambridgeUniversity of Bristol


Got something to say? Make a comment.
Your name
Your email address